NCCLS Interpretive Criteria for Salmonella

Salmonella Infection Clinical Trial

Official title:

NCCLS Interpretive Criteria for Salmonella

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00177658
• Other study ID #: IRB # 0602124 (Old #0303110)
• Status: Completed
• Start date: March 2006
• Est. completion date: June 2017

Study information

• Verified date: June 2018
• Source: University of Pittsburgh
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To determine the clinical significance of gene mutations encoding antibiotic resistance, but not expressed as clinical resistance, in Salmonella bacteria

Description:

Observational study. Physicians in foreign countries caring for patients with Salmonella meningitis or bloodstream infections will collect data on the patients they care for and send this data and an isolate of the organism causing the infection to the University of Pittsburgh.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: June 2017
• Est. primary completion date: June 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• salmonella positive isolate

Related Conditions & MeSH terms

• Salmonella Infection
• Salmonella Infections

Locations

Country	Name	City	State
United States	University of Pittsburgh Medical Center	Pittsburgh	Pennsylvania

Sponsors (2)

Lead Sponsor	Collaborator
University of Pittsburgh	Centers for Disease Control and Prevention

Country where clinical trial is conducted

United States,